Clinical Trial Update: Targeted Treatment Early With Etanercept + Methotrexate vs.T2T Care for DMARD-naïve Early RA Patients Based on naïve T-cell Stratification [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update compares early targeted therapy with Etanercept plus Methotrexate to a treat-to-target strategy in DMARD-naïve patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ENBREL (etanercept)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: University of Leeds | Conditions: Rheumatoid Arthritis | Phase 4 | Status: UNKNOWN